GoingToMeet

Benefit from a mixture of data-driven case-studies and you will learn how to overcome the main challenges in fragment-based design, virtual screening, and affinity prediction and in silico toxicity. With in silico tools becoming a major player in drug design, this is the time to find out how innovative industry has become and how you can utilise key strategies to identify new hit compounds.

Case-study topics include:

* Case-study of the beta-2 adrenergic receptor
* Revealing data of the new beta-1 adrenergic receptor structure
* Advances in generate NMR and X-ray structures
* Molecular modelling
* Astex’s developments in docking/scoring function
* Protein flexibility and affinity prediction
* Chemogenomics
* Toxicity
* Fragment-based drug design
* Virtual screening
* Developments with protein-protein interactions.

If you are a computational/medicinal chemist or structural biologist, or have ties with molecular modelling, informatics or crystallography, then this is the event for you in 2008.